Stefan Sleijfer

2001–2025 年に発表

130
論文数
21,597
被引用数
80
h 指数
127
i10 指数

被引用数

Stefan Sleijfer の年別被引用数1926 年: 被引用 3 件1993 年: 被引用 1 件2000 年: 被引用 2 件2002 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 1 件2005 年: 被引用 8 件2006 年: 被引用 7 件2007 年: 被引用 12 件2008 年: 被引用 35 件2009 年: 被引用 55 件2010 年: 被引用 116 件2011 年: 被引用 137 件2012 年: 被引用 136 件2013 年: 被引用 190 件2014 年: 被引用 153 件2015 年: 被引用 174 件2016 年: 被引用 198 件2017 年: 被引用 186 件2018 年: 被引用 203 件2019 年: 被引用 738 件2020 年: 被引用 907 件2021 年: 被引用 1,033 件2022 年: 被引用 827 件2023 年: 被引用 633 件2024 年: 被引用 989 件2025 年: 被引用 375 件2026 年: 被引用 14 件1927〜1992 年は被引用が無いため表示していません1994〜1999 年は被引用が無いため表示していません2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,203 件、この内訳の 21.3%中国: 引用元論文 986 件、この内訳の 9.5%ドイツ: 引用元論文 690 件、この内訳の 6.7%オランダ: 引用元論文 690 件、この内訳の 6.7%イギリス: 引用元論文 659 件、この内訳の 6.4%イタリア: 引用元論文 638 件、この内訳の 6.2%フランス: 引用元論文 541 件、この内訳の 5.2%スペイン: 引用元論文 346 件、この内訳の 3.4%カナダ: 引用元論文 285 件、この内訳の 2.8%日本: 引用元論文 242 件、この内訳の 2.3%オーストラリア: 引用元論文 241 件、この内訳の 2.3%ベルギー: 引用元論文 218 件、この内訳の 2.1%
0%21.3%その他 25.1%

分野

  • Medicine68.6%
  • Biochemistry, Genetics and Molecular Biology24.4%
  • Immunology and Microbiology3.1%
  • Engineering1.6%
  • Computer Science0.5%
  • Materials Science0.3%
  • その他1.5%

トピック

  • Cancer Genomics and Diagnostics6.4%
  • CAR-T cell therapy research5.4%
  • Sarcoma Diagnosis and Treatment5%
  • Cancer Cells and Metastasis4.1%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Immunotherapy and Immune Responses2.2%
  • その他74%

共著者

全論文

検索で開く
  1. Pan-cancer whole-genome analyses of metastatic solid tumours

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2019 被引用: 1,213

  2. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 989

  3. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 1,621

  4. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 455

  5. Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

    著者: , , , , , , , , , , - Molecular Therapy 2013 被引用: 709

  6. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 被引用: 563

  7. Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

    著者: , , , , , , , , - Journal of Clinical Oncology 2006 被引用: 911

  8. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 被引用: 269

  9. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 751

  10. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 641

  11. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 被引用: 282

  12. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2019 被引用: 333

  13. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 209

  14. Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab

    著者: , , , , , , , , - The Lancet Oncology 2022 被引用: 90

  15. Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells–a completed study overview

    著者: , , , , - Biochemical Society Transactions 2016 被引用: 179

  16. TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Sleijfer, Anders Ullén, Jeffrey Yachnin, Henrik Grönberg, Steven Van Laere, Johan Lindberg, Luc Dirix - Clinical Cancer Research 2018 被引用: 171

  17. Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells

    著者: , , , , , , , , , - Blood 2010 被引用: 367

  18. 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

    著者: , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2018 被引用: 143

  19. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

    著者: , , , , , , , , , , , - Nature Communications 2021 被引用: 124

  20. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells

    著者: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2021 被引用: 92

  21. Side Effects of Interferon-α Therapy

    著者: , , , , - Pharmacy World & Science 2005 被引用: 285

  22. Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 681

  23. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature

    著者: , , , , - The Oncologist 2016 被引用: 224

  24. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy

    著者: , , , , , - The Breast 2016 被引用: 146